L'ibrutinib (936563-96-1) est utilisé dans le traitement de l'infection.
Ibrutinib is a non-receptor Bruton's tyrosine kinase inhibitor approved for the treatment of relapsed chronic lymphocytic leukemia(CLL), mantle cell lymphoma (MCL) and WaldenstrÖm's Macroglobulinemia (WM). Product Name: Ibrutinib CAS No.: 936563-96-1 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C25H24N6O2 Molecular Weight: 440.5 Shelf Life: 2 Years Package: 25kg/drum
5- ((4-phénoxyphényl)-7H-pyrrolo[2,3-d]pyrymidine-4-ylaMine (330786-24-8)
5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine (330786-24-8) is a key intermediate of Ibrutinib. Product Name: 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine CAS No.: 330786-24-8 Assay: 98% End Use: Ibrutinib Molecular Formula: C17H13N5O Molecular Weight: 303.32 Shelf Life: 2 Years Package: 25kg/drum
